ג'מסיטאבין אקטביס 200 מ"ג/בקבוקון

国家: 以色列

语言: 希伯来文

来源: Ministry of Health

有效成分:

GEMCITABINE 200 MG/VIAL

可用日期:

DEVRIES & CO. LTD

ATC代码:

L01BC05

药物剂型:

POWDER FOR SOLUTION FOR INFUSION

给药途径:

I.V

厂商:

ACTAVIS GROUP PTC ehf, ICELAND

治疗组:

GEMCITABINE

疗效迹象:

Gemcitabine is indicated for the treatment of locally advanced or metastatic bladder cancer in combination with cisplatin. Gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas.Gemcitabine, in combination with cisplatin is indicated as first line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). Gemcitabine monotherapy can be considered in elderly patients or those with performance status 2. Gemcitabine is indicated for the treatment of patients with locally advanced or metastatic epithelial ovarian carcinoma, in combination with carboplatin, in patients with relapsed disease following a recurrence-free interval of at least 6 months after platinum-based, first-line therapy. Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherap

授权日期:

2013-06-01